Guo Wei Selected Research

3,4-dihydroxyphenyllactic acid

12/2021	[Corrigendum] Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
11/2017	Danshensu accelerates angiogenesis after myocardial infarction in rats and promotes the functions of endothelial progenitor cells through SDF-1α/CXCR4 axis.
7/2016	Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
2/2015	Neuroprotective effect and underlying mechanism of sodium danshensu [3-(3,4-dihydroxyphenyl) lactic acid from Radix and Rhizoma Salviae miltiorrhizae = Danshen] against cerebral ischemia and reperfusion injury in rats.
1/2015	Effects and Mechanism of Combination of Rhein and Danshensu in the Treatment of Chronic Kidney Disease.
1/2013	Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo Wei Research Topics

Disease

20	Neoplasms (Cancer) 10/2022 - 05/2003
12	Reperfusion Injury 12/2021 - 07/2003
11	Chronic Renal Insufficiency 01/2022 - 02/2011
10	Infarction (Infarctions) 02/2019 - 01/2013
9	Ischemia 09/2021 - 07/2003
8	Myocardial Ischemia (Ischemic Heart Diseases) 12/2021 - 01/2013
7	Inflammation (Inflammations) 09/2021 - 02/2012
7	Stomach Neoplasms (Stomach Cancer) 07/2015 - 04/2005
6	Wounds and Injuries (Trauma) 01/2020 - 08/2008
6	Fibrosis (Cirrhosis) 01/2020 - 08/2015
6	Hypoxia (Hypoxemia) 11/2017 - 07/2003
5	Neoplasm Metastasis (Metastasis) 09/2022 - 04/2005
5	Myocardial Infarction 02/2021 - 06/2013
4	Infections 12/2021 - 12/2014
4	Pain (Aches) 06/2021 - 03/2014
4	Diabetes Mellitus 01/2020 - 03/2014
4	Brain Ischemia (Cerebral Ischemia) 01/2017 - 01/2014
4	Brain Injuries (Brain Injury) 03/2016 - 07/2011
3	Osteosarcoma (Osteogenic Sarcoma) 09/2022 - 08/2010
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2014
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2011
3	Melanoma (Melanoma, Malignant) 02/2021 - 01/2019
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2019
3	Albuminuria 01/2020 - 05/2013
3	Brain Edema (Cerebral Edema) 02/2019 - 07/2011
3	Lung Neoplasms (Lung Cancer) 09/2018 - 12/2014
3	Diabetic Cardiomyopathies 01/2017 - 01/2015
3	Hyperglycemia 01/2017 - 01/2015
3	Sepsis (Septicemia) 03/2016 - 10/2010
3	Kidney Diseases (Kidney Disease) 01/2016 - 02/2011
3	Breast Neoplasms (Breast Cancer) 08/2015 - 05/2003
3	Endometriosis 08/2007 - 06/2005
2	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 11/2021
2	Hemorrhoids 03/2022 - 12/2014
2	COVID-19 01/2022 - 09/2020
2	Stroke (Strokes) 01/2022 - 01/2016
2	Rupture 01/2021 - 10/2019
2	ST Elevation Myocardial Infarction 01/2021 - 10/2020
2	Critical Illness (Critically Ill) 09/2020 - 11/2013
2	Disease Progression 09/2020 - 09/2007
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2016
2	Neuroinflammatory Diseases 02/2019 - 03/2016
2	Ischemic Stroke 02/2019 - 08/2007
2	Carcinogenesis 09/2018 - 05/2015
2	Necrosis 11/2017 - 08/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2017 - 12/2008
2	Wasting Syndrome (Wasting Disease) 09/2017 - 05/2017
2	Acute Lung Injury 03/2016 - 11/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 06/2011
2	Edema (Dropsy) 03/2014 - 07/2011

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 02/2021 - 05/2003
8	CytokinesIBA 02/2019 - 09/2008
7	AntioxidantsIBA 09/2021 - 01/2014
7	Pharmaceutical PreparationsIBA 01/2018 - 08/2006
6	3,4-dihydroxyphenyllactic acidIBA 12/2021 - 01/2013
6	Neuroprotective AgentsIBA 02/2019 - 05/2008
5	C-Reactive ProteinIBA 11/2017 - 02/2012
4	Biomarkers (Surrogate Marker)IBA 09/2022 - 07/2011
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022 - 01/2017
4	Small Interfering RNA (siRNA)IBA 02/2019 - 08/2006
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 04/2017
3	LipidsIBA 02/2021 - 10/2019
3	CreatinineIBA 01/2020 - 02/2011
3	chikusetsu saponin IVaIBA 01/2020 - 12/2015
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2017 - 06/2013
3	Oxygen (Dioxygen)IBA 01/2017 - 01/2012
3	Messenger RNA (mRNA)IBA 07/2011 - 07/2003
2	Circular RNAIBA 10/2022 - 02/2021
2	VaccinesIBA 07/2022 - 03/2008
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 03/2014
2	rheinIBA 05/2020 - 01/2015
2	AlbuminsIBA 01/2020 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 01/2017
2	EnzymesIBA 02/2019 - 11/2013
2	CollagenIBA 10/2018 - 03/2010
2	Malondialdehyde (Propanedial)IBA 11/2017 - 08/2017
2	Superoxide DismutaseIBA 11/2017 - 08/2017
2	Dietary ProteinsIBA 09/2017 - 03/2016
2	FlavonoidsIBA 09/2017 - 04/2013
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2017 - 01/2014
2	protocatechualdehydeIBA 01/2017 - 06/2013
2	AdiponectinIBA 01/2016 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 11/2013
2	Serum AlbuminIBA 07/2015 - 05/2013
2	LuciferasesIBA 05/2015 - 05/2003
2	Carrier Proteins (Binding Protein)IBA 12/2014 - 08/2006
2	Dietary Fiber FDA Link 10/2014 - 02/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2014 - 07/2011
2	MB Form Creatine KinaseIBA 06/2013 - 01/2013

Therapy/Procedure

20	Therapeutics 09/2022 - 04/2005
7	Drug Therapy (Chemotherapy) 09/2022 - 04/2005
4	Photochemotherapy (Photodynamic Therapy) 03/2022 - 01/2017
4	Ligation 11/2017 - 06/2013
3	Renal Dialysis (Hemodialysis) 09/2017 - 06/2015
2	Immunotherapy 03/2022 - 11/2021
2	Secondary Prevention 01/2022 - 09/2021
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2016 - 03/2014
2	Punctures 03/2016 - 11/2013
2	Aftercare (After-Treatment) 08/2015 - 03/2010